Crispr Therapeutics shares owned by Capital International
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital International
from 13F filings
Historical chart of Capital International investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Capital International consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Capital International
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.9M | 126k | 46.98 |
| 2024-03-31 | $8.6M | 127k | 68.16 |
| 2023-12-31 | $5.9M | 95k | 62.60 |
| 2023-09-30 | $4.3M | 95k | 45.39 |
| 2023-06-30 | $5.3M | 95k | 56.14 |
| 2023-03-31 | $4.2M | 93k | 45.23 |
| 2022-12-31 | $3.2M | 78k | 40.65 |
| 2022-09-30 | $5.0M | 76k | 65.35 |
| 2022-06-30 | $2.9M | 48k | 60.77 |
| 2022-03-31 | $2.7M | 43k | 62.77 |
| 2021-12-31 | $3.3M | 43k | 75.77 |
| 2021-09-30 | $4.5M | 40k | 111.93 |
| 2021-06-30 | $6.5M | 40k | 161.89 |
| 2021-03-31 | $5.4M | 44k | 121.85 |
| 2020-12-31 | $11M | 69k | 153.11 |
| 2020-09-30 | $5.7M | 68k | 83.64 |